Avacta appoints Chief Scientific Officer Dr. Michelle Morrow has been appointed as Chief Scientific Officer of Avacta Group plc, effective November 4, 2024. With nearly…
Avacta Group – Exploring NASDAQ Dual-Listing And Divesting Its Diagnostics Division, Analyst Has 188p Valuation, Shares Now 45.5p On Wednesday 30th October, Avacta Group (LON:AVCT), the cancer treatments and diagnostics life sciences business, will be presenting a live…
Avacta Group elects to settle convertible bond payment in cash Avacta Group has announced its decision to settle the upcoming July quarterly amortisation payment for its unsecured convertible bonds in…
PLX: More Regulatory Approvals By John Vandermosten, CFA NYSE:PLX READ THE FULL PLX RESEARCH REPORT Third Quarter 2023 Financial and Operational Review Protalix Biotherapeutics, Inc. (NYSE:PLX) announced 3Q:23…
IN BRIEF: Avacta Group issues 3.8 million shares to make repayment Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta soars on another successful clinical study Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta says AVA6000 fifth dose escalation results "very favourable" Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta Completes Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study Avacta Completes Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study...…
Avacta Group Says No Fundraising Imminent; Shares Rise Avacta Group Says No Fundraising Imminent; Shares Rise...…
Avacta Group Buys Coris Bioconcept for Up to GBP10.4 Mln Avacta Group Buys Coris Bioconcept for Up to GBP10.4 Mln...…
Avacta shares quadrupled in five years! Am I too late to buy? Christopher Ruane thinks the incredible run of Avacta shares over the past few years may have room left to run.…
Avacta 2022 Pretax Loss Widened Despite Higher Revenue Avacta 2022 Pretax Loss Widened Despite Higher Revenue...…
Avacta opens first US clinical investigator sites Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta opens first two clinical investigator sites in US for AVA6000 Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta shares jump 10% on phase I update Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta Groups Shares Rise on US Site Openings for Cancer Study Patient Enrolment Avacta Group's Shares Rise on US Site Openings for Cancer Study Patient Enrolment...…
Avacta doses first patient in fifth cohort of AVA6000 phase 1 study Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Is the Avacta share price dip a buying opportunity? I would buy Avacta at its current share price if I was comfortable with the risk inherent in its developmental…
Is the Avacta share price about to rocket in 2023? The Avacta share price is up an incredible 560% in just three years. But could this exciting biotech be about…
Avacta Shares Rise on Strong Targeting, Safety Results for Tumor Treatment Avacta Shares Rise on Strong Targeting, Safety Results for Tumor Treatment...…
Avacta Group soars after positive phase 1 trial results Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta raises GBP64 million to finance Launch Diagnostics purchase Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Can the Avacta share price make me rich? Is the Avacta share price about to take off again and can it make me rich if I invest now?…
Avacta plans to raise GBP62 million; buys Launch Diagnostics Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta buying Launch Diagnostics for initial £24m Um den gesamten Artikel unter sharecast.com zu lesen, klicken Sie bitte auf die Überschrift...…
Avacta Plans to Raise Up to GBP62 Mln, Buy Launch Diagnostics for GBP37 Mln Avacta Plans to Raise Up to GBP62 Mln, Buy Launch Diagnostics for GBP37 Mln...…